X-PERT 10mg Price

Overview

Welcome to Dwaey, specifically on X-PERT 10mg Tablets/Film-coated page.
This medicine contains an important and useful components, as it consists of Vardenafil.
X-PERT 10mg is available in the market in concentration 10 mg / Tablet and in the form of Tablets/Film-coated.

LABORATORIOS CINFA S.A is the producer of X-PERT 10mg and it is imported from SPAIN, The most popular alternatives of X-PERT 10mg are listed downward .

Mode Of Action

Vardenafil is a phosphodiesterase type-5 inhibitor. It manages erectile dysfunction by increasing the amounts of cyclic guanosine monophosphate (cGMP).

Indication

• Erectile dysfunction

Precaution

Anatomical deformation of the penis; predisposition to priapism e.g. sickle cell anaemia, multiple myeloma, or leukaemia; bleeding disorders or active peptic ulceration; left ventricular outflow obstruction; elderly (? 65 yr). Discontinue and seek medical advice if there is sudden vision loss or decreased vision in one or both eyes or tinnitus, dizziness or sudden loss or decrease in hearing, while taking vardenafil. May cause dizziness or abnormal vision so avoid driving or operating machinery until effects of vardenafil is known. Seek immediate medical advice if erection last > 4 hr.

Side Effects

• Dyspepsia
• vomiting
• headache
• flushing
• dizziness
• visual disturbances
• colour vision changes
• raised intra-ocular pressure
• nasal congestion
• hypersensitivity reactions
• nausea
• photosensitivity reactions
• hypotension
• hypertension
• priapism
• palpitations
• myalgia
• increased creatinine kinase
• sudden decrease or loss of hearing
• tinnitus.

Contra indication

Known prolongation of QT interval (congenital or acquired); men for whom sexual intercourse is inadvisable due to CV risk factors; hypotension (systolic <90 mm Hg); hypertension (systolic >170 mm Hg or diastolic >110 mm Hg); recent stroke or MI (within last 6 mth); unstable angina; severe heart failure; end-stage renal disease requiring dialysis; severe hepatic impairment; known degenerative retinal disorders e.g. retinitis pigmentosa. Women, child.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.